BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1086 related articles for article (PubMed ID: 25642960)

  • 1. Mammalian polymerase θ promotes alternative NHEJ and suppresses recombination.
    Mateos-Gomez PA; Gong F; Nair N; Miller KM; Lazzerini-Denchi E; Sfeir A
    Nature; 2015 Feb; 518(7538):254-7. PubMed ID: 25642960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair.
    Ceccaldi R; Liu JC; Amunugama R; Hajdu I; Primack B; Petalcorin MI; O'Connor KW; Konstantinopoulos PA; Elledge SJ; Boulton SJ; Yusufzai T; D'Andrea AD
    Nature; 2015 Feb; 518(7538):258-62. PubMed ID: 25642963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marked contribution of alternative end-joining to chromosome-translocation-formation by stochastically induced DNA double-strand-breaks in G2-phase human cells.
    Soni A; Siemann M; Pantelias GE; Iliakis G
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():2-8. PubMed ID: 26520366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1 and CtIP promote alternative non-homologous end-joining at uncapped telomeres.
    Badie S; Carlos AR; Folio C; Okamoto K; Bouwman P; Jonkers J; Tarsounas M
    EMBO J; 2015 Feb; 34(3):410-24. PubMed ID: 25582120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The helicase domain of Polθ counteracts RPA to promote alt-NHEJ.
    Mateos-Gomez PA; Kent T; Deng SK; McDevitt S; Kashkina E; Hoang TM; Pomerantz RT; Sfeir A
    Nat Struct Mol Biol; 2017 Dec; 24(12):1116-1123. PubMed ID: 29058711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere-Internal Double-Strand Breaks Are Repaired by Homologous Recombination and PARP1/Lig3-Dependent End-Joining.
    Doksani Y; de Lange T
    Cell Rep; 2016 Nov; 17(6):1646-1656. PubMed ID: 27806302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for human homologous recombination factors in suppressing microhomology-mediated end joining.
    Ahrabi S; Sarkar S; Pfister SX; Pirovano G; Higgins GS; Porter AC; Humphrey TC
    Nucleic Acids Res; 2016 Jul; 44(12):5743-57. PubMed ID: 27131361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement for Parp-1 and DNA ligases 1 or 3 but not of Xrcc1 in chromosomal translocation formation by backup end joining.
    Soni A; Siemann M; Grabos M; Murmann T; Pantelias GE; Iliakis G
    Nucleic Acids Res; 2014 Jun; 42(10):6380-92. PubMed ID: 24748665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgH class switching and translocations use a robust non-classical end-joining pathway.
    Yan CT; Boboila C; Souza EK; Franco S; Hickernell TR; Murphy M; Gumaste S; Geyer M; Zarrin AA; Manis JP; Rajewsky K; Alt FW
    Nature; 2007 Sep; 449(7161):478-82. PubMed ID: 17713479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced non-homologous end joining contributes toward synthetic lethality of pathological RAD51C mutants with poly (ADP-ribose) polymerase.
    Somyajit K; Mishra A; Jameei A; Nagaraju G
    Carcinogenesis; 2015 Jan; 36(1):13-24. PubMed ID: 25292178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapies: DNA polymerase θ-a new target for synthetic lethality?
    Killock D
    Nat Rev Clin Oncol; 2015 Mar; 12(3):125. PubMed ID: 25687907
    [No Abstract]   [Full Text] [Related]  

  • 12. MAD2L2 controls DNA repair at telomeres and DNA breaks by inhibiting 5' end resection.
    Boersma V; Moatti N; Segura-Bayona S; Peuscher MH; van der Torre J; Wevers BA; Orthwein A; Durocher D; Jacobs JJL
    Nature; 2015 May; 521(7553):537-540. PubMed ID: 25799990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA repair: Familiar ends with alternative endings.
    Cho NW; Greenberg RA
    Nature; 2015 Feb; 518(7538):174-6. PubMed ID: 25642961
    [No Abstract]   [Full Text] [Related]  

  • 14. Microhomology-mediated end joining: Good, bad and ugly.
    Seol JH; Shim EY; Lee SE
    Mutat Res; 2018 May; 809():81-87. PubMed ID: 28754468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DNA damage response at dysfunctional telomeres, and at interstitial and subtelomeric DNA double-strand breaks.
    Muraki K; Murnane JP
    Genes Genet Syst; 2018 Jan; 92(3):135-152. PubMed ID: 29162774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative end-joining repair pathways are the ultimate backup for abrogated classical non-homologous end-joining and homologous recombination repair: Implications for the formation of chromosome translocations.
    Iliakis G; Murmann T; Soni A
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():166-75. PubMed ID: 26520387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of homologous recombination by hyperthermia shunts early double strand break repair to non-homologous end-joining.
    Bergs JW; Krawczyk PM; Borovski T; ten Cate R; Rodermond HM; Stap J; Medema JP; Haveman J; Essers J; van Bree C; Stalpers LJ; Kanaar R; Aten JA; Franken NA
    DNA Repair (Amst); 2013 Jan; 12(1):38-45. PubMed ID: 23237939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative NHEJ Pathway Components Are Therapeutic Targets in High-Risk Neuroblastoma.
    Newman EA; Lu F; Bashllari D; Wang L; Opipari AW; Castle VP
    Mol Cancer Res; 2015 Mar; 13(3):470-82. PubMed ID: 25563294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shelterin-Mediated Telomere Protection.
    de Lange T
    Annu Rev Genet; 2018 Nov; 52():223-247. PubMed ID: 30208292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA ligase IV-dependent NHEJ of deprotected mammalian telomeres in G1 and G2.
    Smogorzewska A; Karlseder J; Holtgreve-Grez H; Jauch A; de Lange T
    Curr Biol; 2002 Oct; 12(19):1635-44. PubMed ID: 12361565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.